Potential to improve therapy of chronic myeloid leukemia (cml), especially for patients with older age: incidence, mortality, and survival rates of patients with cml in switzerland from 1995 to

HIGHLIGHTS

• who: Michael Daskalakis and colleagues from the Department of Hematology, Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse, Department of BioMedicalResearch (DMBR), University of Bern, Murtenstrasse, Bern, Switzerland have published the research work: Potential to Improve Therapy of Chronic Myeloid Leukemia (CML), Especially for Patients with Older Age: Incidence, Mortality, and Survival Rates of Patients with CML in Switzerland from 1995 to, in the Journal: (JOURNAL)
• what: The authors aimed to describe time period- and age-dependent outcomes by reporting real-world data of CML patients from Switzerland.
• how: The authors calculated OS . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.